HLNCF
Price
$5.17
Change
+$0.17 (+3.40%)
Updated
Apr 2 closing price
Capitalization
39.92B
ZTS
Price
$159.53
Change
-$3.97 (-2.43%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
77.48B
32 days until earnings call
Ad is loading...

HLNCF vs ZTS

Header iconHLNCF vs ZTS Comparison
Open Charts HLNCF vs ZTSBanner chart's image
HALEON
Price$5.17
Change+$0.17 (+3.40%)
Volume$1.06K
Capitalization39.92B
ZOETIS
Price$159.53
Change-$3.97 (-2.43%)
Volume$23.33K
Capitalization77.48B
HLNCF vs ZTS Comparison Chart
Loading...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLNCF vs. ZTS commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLNCF is a Hold and ZTS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (HLNCF: $5.15 vs. ZTS: $159.61)
Brand notoriety: HLNCF: Not notable vs. ZTS: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HLNCF: 264% vs. ZTS: 107%
Market capitalization -- HLNCF: $39.92B vs. ZTS: $77.48B
HLNCF [@Pharmaceuticals: Other] is valued at $39.92B. ZTS’s [@Pharmaceuticals: Other] market capitalization is $77.48B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLNCF’s FA Score shows that 1 FA rating(s) are green whileZTS’s FA Score has 1 green FA rating(s).

  • HLNCF’s FA Score: 1 green, 4 red.
  • ZTS’s FA Score: 1 green, 4 red.
According to our system of comparison, HLNCF is a better buy in the long-term than ZTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZTS’s TA Score shows that 4 TA indicator(s) are bullish.

  • ZTS’s TA Score: 4 bullish, 5 bearish.

Price Growth

HLNCF (@Pharmaceuticals: Other) experienced а +0.78% price change this week, while ZTS (@Pharmaceuticals: Other) price change was -3.28% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.02%. For the same industry, the average monthly price growth was -2.23%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

ZTS is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZTS($77.5B) has a higher market cap than HLNCF($39.9B). ZTS has higher P/E ratio than HLNCF: ZTS (32.94) vs HLNCF (27.25). HLNCF YTD gains are higher at: 10.470 vs. ZTS (-1.742). ZTS has higher annual earnings (EBITDA): 3.67B vs. HLNCF (2.06B). ZTS has more cash in the bank: 2.04B vs. HLNCF (606M). ZTS has less debt than HLNCF: ZTS (6.76B) vs HLNCF (10.4B). HLNCF has higher revenues than ZTS: HLNCF (11.2B) vs ZTS (8.54B).
HLNCFZTSHLNCF / ZTS
Capitalization39.9B77.5B51%
EBITDA2.06B3.67B56%
Gain YTD10.470-1.742-601%
P/E Ratio27.2532.9483%
Revenue11.2B8.54B131%
Total Cash606M2.04B30%
Total Debt10.4B6.76B154%
FUNDAMENTALS RATINGS
ZTS: Fundamental Ratings
ZTS
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
68
SMR RATING
1..100
20
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
56
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ZTS
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
55%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 8 days ago
58%
Declines
ODDS (%)
Bearish Trend 14 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
55%
View a ticker or compare two or three
Ad is loading...
ZTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PFFL8.720.13
+1.51%
ETRACS 2xMonthly Pay Lvrgd Pref Stk ETN
IHE68.220.58
+0.86%
iShares US Pharmaceuticals ETF
JPIE45.910.01
+0.02%
JPMorgan Income ETF
DAX39.38-0.03
-0.08%
Global X DAX Germany ETF
SARK48.62-2.62
-5.11%
Tradr 2X Short Innovation Daily ETF

HLNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
+3.40%
HLN - HLNCF
49%
Loosely correlated
-0.20%
SGIOF - HLNCF
21%
Poorly correlated
N/A
STEK - HLNCF
11%
Poorly correlated
-0.96%
EAPIF - HLNCF
11%
Poorly correlated
N/A
ZTS - HLNCF
10%
Poorly correlated
+0.98%
More

ZTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZTS has been loosely correlated with SNDL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ZTS jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZTS
1D Price
Change %
ZTS100%
-2.38%
SNDL - ZTS
33%
Loosely correlated
-1.74%
ACET - ZTS
31%
Poorly correlated
-7.32%
HLN - ZTS
29%
Poorly correlated
+2.85%
EVO - ZTS
27%
Poorly correlated
N/A
MKKGY - ZTS
25%
Poorly correlated
-2.16%
More